The Cancer Center has entered a dynamic growth phase with the recruitment of 35 faculty in the past four years. During this period, the Cancer Center has provided significant resources (space and/or financial) for the recruitment of nineteen faculty. CCSG developmental funds were used to support nine of these faculty. Each of the nine faculty recruited with CCSG developmental funds has peer-reviewed funding amounting to $11.28 million (total direct costs). In 2003, the Chancellor of UNMC has given the Cancer Center an additional 43,000 sq. ft. of research space to continue its growth and development over the next five years. In 2002, the state of Nebraska enacted legislation, the Nebraska Tobacco Settlement Funds for Biomedical Research, which will provide significant resources (at least $4.8 million annually) to the University of Nebraska Medical Center for recruitment. Over the next five years, the Cancer Center plans to recruit new faculty in the Eppley Institute for Cancer Research as well as in basic, clinical and population science departments at UNMC. Over the next five years the Cancer Center plans to recruit at least 12 additional faculty in basic cancer research, 5-7 new faculty in clinical/translational research, and at least three additional faculty in cancer epidemiology, control, and prevention. CCSG Developmental funds will be used to support the recruitment of new Cancer Center faculty. The Cancer Center also utilizes resources from the state of Nebraska (including LB595, LB506, and the Nebraska Research Initiative) and philanthropy to provide support for recruitment, pilot projects, and enhancements of shared resources.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA036727-20
Application #
6998246
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-09-20
Project End
2009-07-31
Budget Start
2004-09-20
Budget End
2005-07-31
Support Year
20
Fiscal Year
2004
Total Cost
$174,147
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Barkeer, Srikanth; Chugh, Seema; Karmakar, Saswati et al. (2018) Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells. BMC Cancer 18:1157
Cserhati, Matyas F; Mooter, Mary-Ellen; Peterson, Lauren et al. (2018) Motifome comparison between modern human, Neanderthal and Denisovan. BMC Genomics 19:472
Napon, Geoffroy; Dafferner, Alicia J; Saxena, Ashima et al. (2018) Identification of Carboxylesterase, Butyrylcholinesterase, Acetylcholinesterase, Paraoxonase, and Albumin Pseudoesterase in Guinea Pig Plasma through Nondenaturing Gel Electrophoresis. Comp Med 68:367-374
Luan, Haitao; Mohapatra, Bhopal; Bielecki, Timothy A et al. (2018) Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program. Cancer Res 78:2524-2535
Rana, Sandeep; Sonawane, Yogesh A; Taylor, Margaret A et al. (2018) Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy. Bioorg Med Chem Lett 28:3736-3740
Azadmanesh, Jahaun; Borgstahl, Gloria E O (2018) A Review of the Catalytic Mechanism of Human Manganese Superoxide Dismutase. Antioxidants (Basel) 7:
Chhonker, Yashpal S; Haney, Staci L; Matthiesen, Robert A et al. (2018) Quantitative determination of a potent geranylgeranyl diphosphate synthase inhibitor using LC-MS/MS: Derivatization and application. J Pharm Biomed Anal 153:22-28
Haney, Staci L; Chhonker, Yashpal S; Varney, Michelle L et al. (2018) Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitor. Invest New Drugs 36:810-818
Saxena, Sugandha; Hayashi, Yuri; Wu, Lingyun et al. (2018) Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Oncotarget 9:5931-5943
Lockridge, Oksana; David, Emilie; Schopfer, Lawrence M et al. (2018) Purification of recombinant human butyrylcholinesterase on Hupresin®. J Chromatogr B Analyt Technol Biomed Life Sci 1102-1103:109-115

Showing the most recent 10 out of 1372 publications